Brian White

Brian White has a diverse work experience in the pharmaceutical industry, starting as a Contractor at Infinity Pharmaceuticals in 2008. Brian then moved on to Sirtris Pharmaceuticals where they worked as a Scientist I and later as a Scientist II, focusing on designing and synthesizing novel small molecules as SIRT1 activators. Subsequently, they joined Tarveda Therapeutics, progressing from Senior Scientist to Research Leader and finally to Associate Director. In these roles, they led chemist on the somatostatin receptor 2 (SSTR2) targeting Pentarin program, overseeing the synthesis of drug conjugates for various applications. Most recently, Brian has been working as a Principal Scientist at FogPharma since 2019.

Brian White has a Bachelor of Science in Chemistry from Emory University (1996-2000), a Ph.D. in Chemistry from Boston College (2000-2006), and completed a Postdoctoral associate program in Chemistry at Harvard University (2006-2008).